Propionyl-L-carnitine shows particular promise for peripheral vascular disease and heart failure, with some trials demonstrating improved exercise tolerance.[8][9] LCAR supplementation improves glucolipid metabolism, reducing fasting glucose, insulin resistance, triglycerides, and liver enzymes.[10] Both compounds exhibit excellent safety profiles with minimal side-effects, though recent data raises concerns about substantial TMAO production (reaching 50 M plasma levels) from both supplements, which may have adverse cardiovascular implications.[1][8][3] References Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
In a 52-week phase 2 study published in the New England Journal of Medicine, participants with obesity but without type 2 diabetes lost up to around 20%, with no sign of a weight-loss plateau, while those who also had diabetes lost up to around 17%
Here are five key components to successful medically-monitored weight management: 1
Notably, individuals with severe kidney disease should refrain from using the medication unless specifically instructed by a physician
doi: 10.3390/life11050404 113 De JongFCRuttenVCZuiverloonTCMTheodorescuD